Massive fraud in Medicare‘s prescription drug programs may be going untracked, according to a government watchdog.

“Because the” Centers for Medicare and Medicaid “does not have data on potential fraud and abuse for more than half of Part D plans, it cannot assess the efficacy throughout the Part D program of sponsors’ efforts to control fraud and abuse,” said the inspector general for the Department of Health and Human Services.